Peter is the Managing Partner of CATALYSIS CAPITAL PARTNERS, heading the Firm’s financial and strategic advisory services. Prior to founding CATALYSIS in 2005, Peter was a retained financial advisor to several healthcare companies in Europe and the United States as well as a strategic advisor to TVM Capital.
Until 2002, Peter was a Managing Director and member of the Management Committee of Robertson Stephens Inc. a renowned international investment bank focused on emerging growth healthcare and technology companies. During his tenure at Robertson Stephens, Peter worked in San Francisco, London and Munich as Head of the Firm’s European Healthcare Investment Banking franchise. In 2000, he was appointed to also lead the German investment banking operations of Robertson Stephens International Ltd. in Munich.
He began his career in the life sciences industry as Vice President, Finance and Administration with the Henri Beaufour Institute USA, Inc., a wholly owned biotechnology subsidiary of the Ipsen Group in France.
Peter holds an MBA in international finance from George Washington University and a BS in Foreign Service from Georgetown University.
Peter has served on the Board of Directors of a number of privately-held life science and animal health companies.